title: Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').
authors.forename: E
authors.initials: E
authors.lastname: Alvarez-Cuesta
authors.forename: J
authors.initials: J
authors.lastname: Bousquet
authors.forename: W G
authors.initials: WG
authors.lastname: Canonica
authors.forename: S
authors.initials: S
authors.lastname: Durham
authors.forename: H-J
authors.initials: HJ
authors.lastname: Malling
authors.forename: G
authors.initials: G
authors.lastname: Passalacqua
authors.forename: E
authors.initials: E
authors.lastname: Valovirta
mesh_terms: D000485:Allergens; D003888:Desensitization, Immunologic / Q000592:standards*; D004837:Epinephrine / Q000008:administration & dosage; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D007273:Injections, Intramuscular
chemical_list: D000485:Allergens; D004837:Epinephrine